NASDAQ: FOLD

Market Summary

Predicting Amicus Therapeutics Inc’s (FOLD) earnings for the current quarter

Cameron Mitchell

Amicus Therapeutics Inc (FOLD)’s stock has witnessed a price hike of 0.12% from the previous close with its current price ...

Analyst Snapshot

FOLD’s price-to-free cash flow ratio: What it means for investors

Cameron Mitchell

Currently, Amicus Therapeutics Inc’s (FOLD) stock is trading at $9.38, marking a fall of -0.42% from last night’s close. At ...

Market Summary

How analysts predict Amicus Therapeutics Inc (FOLD) will perform this quarter?

Cameron Mitchell

Amicus Therapeutics Inc (FOLD)’s stock is trading at $8.92 at the moment marking a rise of 0.28% from the last ...

US Post News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.